Los Angeles Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-39,803
| Closed | -$1.11M | – | 1332 |
|
|
2019
Q2 | $1.11M | Sell |
39,803
-18,770
| -32% | -$522K | 0.01% | 818 |
|
|
2019
Q1 | $1.95M | Sell |
58,573
-7,280
| -11% | -$242K | 0.01% | 662 |
|
|
2018
Q4 | $1.91M | Buy |
65,853
+6,445
| +11% | +$187K | 0.01% | 565 |
|
|
2018
Q3 | $2.73M | Buy |
59,408
+41,908
| +239% | +$1.93M | 0.01% | 586 |
|
|
2018
Q2 | $654K | Sell |
17,500
-8,390
| -32% | -$314K | ﹤0.01% | 1056 |
|
|
2018
Q1 | $765K | Buy |
25,890
+20,050
| +343% | +$592K | ﹤0.01% | 904 |
|
|
2017
Q4 | $201K | Buy |
+5,840
| New | +$201K | ﹤0.01% | 1272 |
|
|
2014
Q1 | – | Sell |
-18,041
| Closed | -$379K | – | 1291 |
|
|
2013
Q4 | $379K | Buy |
+18,041
| New | +$379K | ﹤0.01% | 1008 |
|